Complete molecular remission induced by concomitant cladribine--rituximab treatment in a case of multi-resistant hairy cell leukemia.
Forconi
Francesco
F
Toraldo
Francesca
F
Sozzi
Elisa
E
Amato
Teresa
T
Raspadori
Donatella
D
Lauria
Francesco
F
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017338:Cladribine / Q000008:administration & dosage*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics; D007135:Immunoglobulin Variable Region / Q000235:genetics; D007943:Leukemia, Hairy Cell / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007143:Immunoglobulin Heavy Chains; D007135:Immunoglobulin Variable Region; D017338:Cladribine; D000069283:Rituximab